期刊文献+

Survivin及P16基因在非小细胞肺癌中的表达及相关性 被引量:2

下载PDF
导出
摘要 目的:探讨Survivin基因在非小细胞肺癌(NSCLC)中的表达及其与P16蛋白表达的相互关系。方法:应用免疫组织化学法检测120例非小细胞肺癌组织及20例肺良性病变组织中survivin、P16蛋白的表达情况。结果:Survivin蛋白在61.7%的NSCLC组织中有表达,在肺良性病变组织中不表达,且survivin的表达与肺癌患者的TNM分期有关;P16基因在肺良性病变组织中不表达,其阳性表达率在鳞癌中为17.65%,在腺癌中为53.85%,差异具有显著性(P<0.05)。结论:Survivin基因在非小细胞肺癌中表达上调,提示其对NSCLC的发生发展起重要作用,提示可作为判断病情及预后的指标。Survivin基因与抑癌基因P16的蛋白表达呈正相关,二者可能在肺癌中起协同作用。
作者 徐荡 朱润庆
出处 《中国社区医师(医学专业)》 2011年第28期238-239,共2页
  • 相关文献

参考文献3

  • 1Suzuki A,Ito T,Kawano H,et al.Survivin in itiates procasepase3/P21 complex formation as a result of interaction with CDK4 to resist Fas-mediated cell death[J].Oncogene,2000,19(10):1346-1353.
  • 2Uzuki A,Hayashida M,Ito T,et al.Survivin in itiates cell cycle entry by the competitive interaction with CDK4/p16 and CDK2/cyclinE complex activation[J].Oncogene,2000,19(29):3225.
  • 3Kukhta VK,Marozkina NK,Sokolchik IG,et al.Molecular mechanisms of apoptosis[J].Ukr Biokhin Zh,2003,75(6):5-9.

同被引文献35

  • 1程锦霖,阮永华,金克炜.p16基因甲基化与肺癌早期诊断[J].中国肺癌杂志,2006,9(3):295-297. 被引量:8
  • 2Mary J. New tumor suppressor mayrival P53 [ J ]. Science,1994,264:344.
  • 3Kamb A,Gruis NA,Weaver - Feldhaus J,et al. A cell cycle-regulator potentially involved in genesis of many tumor types[J]. Science,1994,264(5157) :436 -440.
  • 4Laura Bonetta. Open question on P16 [ J] . Nature 1994;21(370) :180.
  • 5Serrano M, Hannon GJ, Beach D. A new regulatory motif incell-cycle control causing specific inhibition of cyclin D/CDK4[J]. Nature,1993,366( 6456) :704 -707.
  • 6Cheng JQ , Jhanwar SC, lu YY,et al. Homozygousdeletionswithin 9p21 - p22 identify a small critical region of chromo-somal loss in human malignant mesotheliomas [ J ] . CancerRes, 1993,53 :4761 -4763.
  • 7Paya A, Alenda C,Perez - Carbonell L,et al. Utility of pl6immunohistochemisty for the identification of Lynch syn-drome [J]. Clin CancerRes,2009,15(9) :3156 -3162.
  • 8Cao J, Zhou J,Gao Y,et al. Methylation of pi6 CpG islandassociated with malignant progression of oral epithelial dys-plasia :a prospective cohort study [ J ] . Clin Cancer ,2009 ,15(16):5178 -5183.
  • 9Zhou Jing, Su Yu-wen. SAM, DNA methylation and tumor[J ] . Journal of Modem Oncology,2008,16 ( 11 ) : 2019 -2021.
  • 10Shakera S,Bemsteinb M,Momparler LF,et al. Preclinical e-valuation of antineoplastic activity of inhibitors of DNAmethylation ( 5-aza-2-deoxycytidine ) and histone deacetyla-tion ( trichostatin A, depsipeptide ) in combination againstmyeloidleukemic cells[ J]. Leuk Res,2003,27 (5 ) ?? 437 -444.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部